Abbvie Clinical Trials for Myelofibrosis and Acute Myeloid Leukemia
Posted June 30, 2022
Myelofibrosis Transform-1 (M16-191) Phase 3 Study Of Navitoclax In Combination With Ruxolitinib Versus Ruxolitinib In Subjects With Myelofibrosis FL sites: Lynn Cancer Institute in Boca FCS South FCS East FCS North gov: https://www.clinicaltrials.gov/ct2/show/NCT04472598 Acute Myeloid Leukemia Viale-T (M19-063) Phase 3 Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine After Allogeneic Stem Cell...